Követés
Dr Puneet Utreja
Dr Puneet Utreja
Director-Principal, PCTE Group of Institutes, Ludhiana
E-mail megerősítve itt: pcte.edu.in
Cím
Hivatkozott rá
Hivatkozott rá
Év
Elastic Liposomal Formulation for Sustained Delivery of Colchicine: In Vitro Characterization and In Vivo Evaluation of Anti-gout Activity
HP Singh, P Utreja, AK Tiwary, S Jain
The AAPS journal 11, 54-64, 2009
1252009
Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy
S Verma, P Utreja
Asian journal of pharmaceutical sciences 14 (2), 117-129, 2019
1202019
An overview of therapeutic effects of vanillic acid
N Sharma, N Tiwari, M Vyas, N Khurana, A Muthuraman, P Utreja
Plant Arch 20 (2), 3053-3059, 2020
1012020
Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospects
P Utreja, S Jain, A K Tiwary
Current Drug Delivery 7 (2), 152-161, 2010
982010
Advanced drug delivery systems for transdermal delivery of non-steroidal anti-inflammatory drugs: A review
L Kumar, S Verma, M Singh, T Chalotra, P Utreja
Current drug delivery 15 (8), 1087-1099, 2018
972018
Poly propyl ether imine (PETIM) dendrimer: A novel non-toxic dendrimer for sustained drug delivery
S Jain, A Kaur, R Puri, P Utreja, A Jain, M Bhide, R Ratnam, V Singh, ...
European journal of medicinal chemistry 45 (11), 4997-5005, 2010
732010
Localized delivery of paclitaxel using elastic liposomes: formulation development and evaluation
P Utreja, S Jain, AK Tiwary
Drug Delivery 18 (5), 367-376, 2011
612011
Formulation and characterization of transethosomes for enhanced transdermal delivery of propranolol hydrochloride
L Kumar, P Utreja
Micro and nanosystems 12 (1), 38-47, 2020
452020
Transethosomes of econazole nitrate for transdermal delivery: Development, in-vitro characterization, and ex-vivo assessment
S Verma, P Utreja
Pharmaceutical Nanotechnology 6 (3), 171-179, 2018
382018
Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation
P Utreja, S Jain, AK Tiwary
Drug delivery 19 (1), 11-20, 2012
362012
Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities
L Kumar, S Verma, K Joshi, P Utreja, S Sharma
Future Journal of Pharmaceutical Sciences 7 (1), 175, 2021
342021
Use of nanoparticles in medicine
P Utreja, S Verma, M Rahman, L Kumar
Current Biochemical Engineering 6 (1), 7-24, 2020
332020
Paclitaxel loaded nanoliposomes in thermosensitive hydrogel: A dual approach for sustained and localized delivery
M Mahajan, P Utreja, S Kumar Jain
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016
292016
Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model
N Sharma, N Khurana, A Muthuraman, P Utreja
European journal of pharmacology 903, 174112, 2021
282021
Recent advances in drug delivery systems for anti-diabetic drugs: a review
M Grover, P Utreja
Current Drug Delivery 11 (4), 444-457, 2014
262014
Nanotechnological carriers for treatment of acne
S Verma, P Utreja, L Kumar
Recent patents on anti-infective drug discovery 13 (2), 105-126, 2018
232018
Nanostructured lipid carriers and their application in drug delivery
S Khurana, P Utreja, AK Tiwary, NK Jain, S Jain
International Journal of Biomedical Engineering and Technology 2 (2), 152-171, 2009
222009
Efficacy and toxicological studies of cremophor EL free alternative paclitaxel formulation
P Utreja, S Jain, S Yadav, K L. Khandhuja, A K. Tiwary
Current drug safety 6 (5), 329-338, 2011
192011
Elastic liposomal formulation for sustained delivery of colchicine
HP Singh, P Utreja, AK Tiwary, S Jain
in vitro characterization and in vivo evaluation of anti-gout activity 2009, 11, 2008
142008
Gold nanoparticles and their applications in cancer treatment
S Verma, P Utreja, M Rahman, L Kumar
Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 8 (3), 184-201, 2018
132018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20